---
figid: PMC4383151__BMRI2015-548436.001
figlink: /pmc/articles/PMC4383151/figure/fig1/
number: F1
caption: Mechanisms of metformin action to inhibit cancer. Metformin disrupts circulating
  glucose and insulin levels and reduces inflammation. The organic cation transporter
  (OCT1) mediates the first step in metformin cellular response [–]. (1) Metformin
  activates the AMPK-P pathway through inhibition of Complex 1 of the mitochondrial
  respiratory chain [, ]. This leads to the inhibition of mTOR and thus loss of cell
  proliferation and inhibition of glucose synthesis [–]. (2) LKB1 may act as an intermediatory
  of AMPK activation [, ]. (3) Metformin blocks cAMP and PKA, which in turn antagonizes
  glucagon action []. (4) Metformin acts as an antifolate hindering DNA replication
  []. (5) Metformin induces an anti-inflammatory response via the Src-mediated NF-κΒ
  pathway []. (6) Metformin action is implicated in both AMPK dependent and independent
  inhibition of the angiogenesis process [].
pmcid: PMC4383151
papertitle: 'Recent Advances in the Use of Metformin: Can Treating Diabetes Prevent
  Breast Cancer?.'
reftext: Diana Hatoum, et al. Biomed Res Int. 2015;2015:548436.
pmc_ranked_result_index: '9616'
pathway_score: 0.9363855
filename: BMRI2015-548436.001.jpg
figtitle: Metformin action to inhibit cancer
year: '2015'
organisms: Homo sapiens
ndex: c9a80bb1-df07-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4383151__BMRI2015-548436.001.html
  '@type': Dataset
  description: Mechanisms of metformin action to inhibit cancer. Metformin disrupts
    circulating glucose and insulin levels and reduces inflammation. The organic cation
    transporter (OCT1) mediates the first step in metformin cellular response [–].
    (1) Metformin activates the AMPK-P pathway through inhibition of Complex 1 of
    the mitochondrial respiratory chain [, ]. This leads to the inhibition of mTOR
    and thus loss of cell proliferation and inhibition of glucose synthesis [–]. (2)
    LKB1 may act as an intermediatory of AMPK activation [, ]. (3) Metformin blocks
    cAMP and PKA, which in turn antagonizes glucagon action []. (4) Metformin acts
    as an antifolate hindering DNA replication []. (5) Metformin induces an anti-inflammatory
    response via the Src-mediated NF-κΒ pathway []. (6) Metformin action is implicated
    in both AMPK dependent and independent inhibition of the angiogenesis process
    [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAB1
  - PRKAR2A
  - PRKAR2B
  - PRKACB
  - PRKACG
  - RELB
  - PRKAA1
  - NFKB2
  - RELA
  - PRKAG3
  - MTOR
  - NFKB1
  - STK11
  - REL
  - PLXNA2
  - PRKAG2
  - PRKAB2
  - PRKAG1
  - MFAP1
  - SRC
  - PRKAR1A
  - PRKAA2
  - PRKAR1B
  - PRKACA
  - Folate
  - Glucose
  - Metformin
genes:
- word: AMPK-P
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: →NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: AMPK-P
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: →NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: →NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: AMPK-P
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: →NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: STK11/LKB1?
  symbol: LKB1
  source: hgnc_alias_symbol
  hgnc_symbol: STK11
  entrez: '6794'
- word: →NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: Oct
  symbol: OCT
  source: hgnc_alias_symbol
  hgnc_symbol: PLXNA2
  entrez: '5362'
- word: AMPK-P
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK-P
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK-P
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: ATP/AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: Src?
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: STK11/LKB1?
  symbol: STK11
  source: hgnc_symbol
  hgnc_symbol: STK11
  entrez: '6794'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: AMPK-P
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
chemicals:
- word: Folate
  source: MESH
  identifier: D005492
- word: Glucose
  source: MESH
  identifier: D005947
- word: Metformin
  source: MESH
  identifier: D008687
diseases: []
figid_alias: PMC4383151__F1
redirect_from: /figures/PMC4383151__F1
figtype: Figure
---
